Dual-Vector Tachycardia Detection Algorithm for SVT VT Discrimination
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current implantable cardioverter defibrillators face challenges in accurately distinguishing between supraventricular tachycardia (SVT) and ventricular tachycardia (VT), leading to inappropriate therapy delivery and potential battery inefficiency due to the similarity in tachycardia cycle lengths and retrograde conduction patterns.
Innovation Solution
A tachycardia detection algorithm utilizing dual-vector EGM sensing to estimate heart rates and apply beat-by-beat rules for discriminating between VT and SVT, incorporating RR interval analysis and morphology scoring to accurately classify rhythms and guide appropriate therapy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If tachycardia detection relies on standard single-vector sensing, then the detection method is simple, but the discrimination accuracy between SVT and VT is insufficient
Solution Approach 1:
The patent divides the sensing function into multiple independent vectors (first sensing vector and second sensing vector), each providing separate EGM signals. This segmentation allows the system to compare morphology across different sensing pathways, significantly improving the ability to discriminate between SVT and VT while maintaining manageable complexity through modular signal processing channels.
Solution Approach 2:
The patent adds a spatial dimension to tachycardia detection by introducing multiple sensing vectors with different orientations and locations. By comparing EGM morphology across these different spatial dimensions, the system gains enhanced discrimination capability without requiring complex single-vector analysis, effectively using dimensional diversity to improve measurement precision.
2Reliability
If high-voltage cardioversion shocks are delivered to terminate tachycardia, then therapy delivery is effective, but battery charge is consumed rapidly and patient comfort is reduced
Solution Approach 1:
The patent performs preliminary tachycardia discrimination using dual-vector EGM morphology analysis before committing to high-voltage shock therapy. By accurately classifying the tachycardia type (SVT vs VT) in advance, the system can select appropriate therapy pathways, potentially avoiding unnecessary high-voltage shocks and thereby conserving battery charge while maintaining effective treatment for true ventricular tachycardia cases.
Solution Approach 2:
The system uses feedback from dual-vector EGM signal comparison to continuously monitor and reassess tachycardia characteristics. This feedback mechanism allows the device to confirm the persistence and nature of the arrhythmia before escalating to high-voltage therapy, ensuring that shocks are delivered only when truly necessary and improving overall therapy effectiveness while reducing unnecessary energy consumption.
3Use of energy by moving object
If ATP regimens are used to terminate tachycardia, then battery charge is conserved, but therapy success rate decreases for certain arrhythmia types
Solution Approach 1:
The patent implements dynamic therapy selection based on real-time tachycardia classification. The system adapts the therapy pathway (ATP vs. shock) according to the discriminated arrhythmia type, allowing conservative ATP regimens for SVT cases while reserving high-voltage therapy for VT cases where ATP is less effective. This dynamic adjustment optimizes both battery conservation and therapy success rates.
Solution Approach 2:
The system changes the therapy parameter (ATP amplitude, duration, or escalation to shock) based on the discriminated tachycardia characteristics. By modifying therapy parameters according to the classified arrhythmia type, the system achieves successful termination with minimal energy expenditure for SVT while ensuring adequate therapy intensity for VT, thereby balancing battery conservation with treatment effectiveness.
4Measurement precision
If tachycardia classification is delayed to improve accuracy, then discrimination precision improves, but response time to deliver therapy is extended
Solution Approach 1:
The patent applies partial morphology analysis rules that can quickly classify obvious cases while reserving more comprehensive analysis for ambiguous situations. By using a tiered approach where simple morphological features provide rapid initial classification, the system achieves good discrimination accuracy for clear-cut cases without excessive delay, while still having the capability to perform more thorough analysis when needed.
Solution Approach 2:
The dual-vector EGM sensing system acts as an intermediary that provides additional discriminative information without requiring extended analysis time. The morphology comparison between two vectors offers immediate discriminatory power that accelerates accurate classification, serving as a mediator between rapid detection and precise discrimination, thereby reducing the time-accuracy trade-off.
Data Source
AI summary
A medical device and associated method for discriminating cardiac events includes determining whether a cardiac evidence counter is greater than a predetermined detection threshold, advancing from a concerned state to a convinced state in response to the evidence counter being greater than the predetermined detection threshold, determining whether a reduction in the cardiac evidence counter occurs while in the convinced state, determining whether one of a first rate corresponding to the first sensing vector and a second rate corresponding to the second sensing vector is less than a predetermined rate limit, and determining whether to advance from the convinced state to one of a therapy delivery state, the concerned state and the unconcerned state in response to determining whether one of the first rate and the second rate is less than a predetermined rate limit.